DGAT1 inhibitor (Hanmi)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDGAT1 inhibitor (Hanmi)
Drug Alias Namediacylglycerol O acyltransferase 1 inhibitor (Hanmi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase 1 inhibitors
TargetsDiacylglycerol O-acyltransferase 1
Therapy Area/IndicationsObesityNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsObesityNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A